OpenBilldrug price receipt

NADAC week of 2026-10-14

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET

For 30 tablets

Pharmacies pay

$3.67 filed

30 × $0.12231 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$9.22 estimated

$3.67 + $0.55 (15%) + $5.00 fee per fill = $9.22

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “butalbital, acetaminophen and caffeine” and “butalbital, acetaminophen, and caffeine”, as its NDCs’ listings variously write the nonproprietary name, under the trade name “Butalbital, Acetaminophen, Caffeine”.

FDA gives its dosage form as tablet and its route as oral.

FDA lists 10 labelers (the companies named on the label) for its NDCs, among them Lannett Company, Inc., Actavis Pharma, Inc. and Major Pharmaceuticals.

FDA lists it under 3 Established Pharmacologic Classes: Barbiturate, Central Nervous System Stimulant and Methylxanthine.

The NADAC file of 2026-10-14 prices it under 20 NDCs (National Drug Codes); the FDA directory lists 17 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $3.67 for 30 tablets (30 × $0.12231 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 10 labelers

LabelerNDCsPharmacies pay per unit
Actavis Pharma, Inc.2$0.12231 per EA filed
Granules Pharmaceuticals Inc.2$0.12231 per EA filed
KVK-Tech, Inc.2$0.12231 per EA filed
Lannett Company, Inc.2$0.12231 per EA filed
Mikart, LLC2$0.12231 per EA filed
QUAGEN PHARMACEUTICALS LLC2$0.12231 per EA filed
Westminster Pharmaceuticals, LLC2$0.12231 per EA filed
AvPAK1$0.12231 per EA filed
Chartwell RX, LLC1$0.12231 per EA filed
Major Pharmaceuticals1$0.12231 per EA filed
Not listed as a package in the FDA directory3$0.12231 per EA filed
All 20 NDCs, with labeler and price
  • 00527-1695-01 · Lannett Company, Inc. · $0.12231 per EA · eff. 2026-09-23 filed
  • 00527-1695-05 · Lannett Company, Inc. · $0.12231 per EA · eff. 2026-09-23 filed
  • 00591-3369-01 · Actavis Pharma, Inc. · $0.12231 per EA · eff. 2026-09-23 filed
  • 00591-3369-05 · Actavis Pharma, Inc. · $0.12231 per EA · eff. 2026-09-23 filed
  • 00904-6938-06 · Major Pharmaceuticals · $0.12231 per EA · eff. 2026-09-23 filed
  • 10702-0253-01 · KVK-Tech, Inc. · $0.12231 per EA · eff. 2026-09-23 filed
  • 10702-0253-50 · KVK-Tech, Inc. · $0.12231 per EA · eff. 2026-09-23 filed
  • 46672-0053-10 · Mikart, LLC · $0.12231 per EA · eff. 2026-09-23 filed
  • 46672-0053-50 · Mikart, LLC · $0.12231 per EA · eff. 2026-09-23 filed
  • 50268-0553-11 · not listed as a package in the FDA directory · $0.12231 per EA · eff. 2026-09-23 filed
  • 50268-0553-13 · AvPAK · $0.12231 per EA · eff. 2026-09-23 filed
  • 62135-0751-01 · Chartwell RX, LLC · $0.12231 per EA · eff. 2026-09-23 filed
  • 64380-0157-01 · not listed as a package in the FDA directory · $0.12231 per EA · eff. 2026-09-23 filed
  • 64380-0157-02 · not listed as a package in the FDA directory · $0.12231 per EA · eff. 2026-09-23 filed
  • 69367-0203-01 · Westminster Pharmaceuticals, LLC · $0.12231 per EA · eff. 2026-09-23 filed
  • 69367-0203-05 · Westminster Pharmaceuticals, LLC · $0.12231 per EA · eff. 2026-09-23 filed
  • 70010-0149-01 · Granules Pharmaceuticals Inc. · $0.12231 per EA · eff. 2026-09-23 filed
  • 70010-0149-05 · Granules Pharmaceuticals Inc. · $0.12231 per EA · eff. 2026-09-23 filed
  • 70752-0142-10 · QUAGEN PHARMACEUTICALS LLC · $0.12231 per EA · eff. 2026-09-23 filed
  • 70752-0142-14 · QUAGEN PHARMACEUTICALS LLC · $0.12231 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

3 other products in the NADAC file share an FDA nonproprietary name with BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE
generic · capsule
$0.31632 per EA filed
eff. 2026-09-23
We don’t know yet
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG CAPSULE
generic · capsule
$1.93118 per EA filed
eff. 2026-09-23
We don’t know yet
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET this page
generic · tablet
$0.12231 per EA filed
eff. 2026-09-23
We don’t know yet
FIORICET 50-300-40 MG CAPSULE
brand · capsule
$8.82367 per EA filed
eff. 2026-01-01
$7.02553 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 20 NDCs’ NADAC prices is $0.12231 per EA filed.

Of the 10 other products in FDA’s Barbiturate class priced per EA, 10 have a higher middle NADAC price and 0 a lower one. The one in the middle is BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE, at $0.94823 per EA filed (eff. 2026-09-23).

Of the 203 other products in FDA’s Central Nervous System Stimulant class priced per EA, 187 have a higher middle NADAC price and 16 a lower one. The one in the middle is FOCALIN XR 5 MG CAPSULE, at $4.70352 per EA filed (eff. 2026-09-23).

Of the 32 other products in FDA’s Methylxanthine class priced per EA, 16 have a higher middle NADAC price and 16 a lower one. The one in the middle is QC STAY AWAKE 200 MG TABLET, at $0.08299 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.